Die Fundamentaldaten des Unternehmens sind relativ sehr gesund. Seine Bewertung wird als unterbewertet angesehen,und die institutionelle Anerkennung ist sehr hoch. In den letzten 30 Tagen haben mehrere Analysten die Aktie mit einer Kaufen bewertet. Das Unternehmen schneidet an der Börse gut ab, mit starken Fundamentaldaten und technischen Aspekten, die den aktuellen Trend unterstützen. Der Aktienkurs bewegt sich seitwärts zwischen den Unterstützungs- und Widerstandsniveaus, was ihn für schwankungsorientiertes Trading geeignet macht.
Aktienbewertung
Zugehörige Informationen
Branchenrang
92 / 470
Gesamtwertung
157 / 4720
Branche
Software & IT-Dienstleistungen
Widerstand & Unterstützung
Keine Daten
Radar Chart
Aktueller Preis
Vorher
Analysten-Ziel
Basierend auf insgesamt
18
Analysten
Kaufen
Aktuelles Rating
212.837
Kursziel
+36.55%
Aufwärtspotenzial
Hinweis: Analystenbewertungen und Kursziele werden von LSEG ausschließlich zu Informationszwecken bereitgestellt und stellen keine Anlageberatung dar.
Unternehmens-Highlights
HöhepunkteRisiko
EPAM Systems, Inc. provides digital engineering, cloud, and artificial intelligence-enabled transformation services. The Company's software product and platform development services, including product research, customer experience design and prototyping, program management, component design and integration, full lifecycle software testing, product deployment and end-user customization, performance tuning, product support and maintenance, managed services, as well as cross-platform migration and modernizing legacy platforms. Its segments include North America and Europe. It offers complex software product development services. It partners with global pharmaceutical, medical and scientific technology, biotechnology companies and retail pharmacies to deliver scientific informatics and enterprise technology solutions. It offers health data analytics. It also offers a set of AI-enabled capabilities to clients in banking, capital markets and other financially regulated businesses.
EPAM Systems, Inc. provides digital engineering, cloud, and artificial intelligence-enabled transformation services. The Company's software product and platform development services, including product research, customer experience design and prototyping, program management, component design and integration, full lifecycle software testing, product deployment and end-user customization, performance tuning, product support and maintenance, managed services, as well as cross-platform migration and modernizing legacy platforms. Its segments include North America and Europe. It offers complex software product development services. It partners with global pharmaceutical, medical and scientific technology, biotechnology companies and retail pharmacies to deliver scientific informatics and enterprise technology solutions. It offers health data analytics. It also offers a set of AI-enabled capabilities to clients in banking, capital markets and other financially regulated businesses.